Garry Nolan - 13 Dec 2022 Form 4/A - Amendment Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Garry Nolan, by Brian McKelligon, as Attorney-in-Fact
Issuer symbol
AKYA
Transactions as of
13 Dec 2022
Net transactions value
-$1,325
Form type
4/A - Amendment
Filing time
27 Mar 2023, 20:12:43 UTC
Date Of Original Report
15 Dec 2022
Previous filing
06 Dec 2022
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale $1,325 -100 -0.02% $13.25 555,084 13 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4/A is being filed to correct the date of the transaction which was inadvertently reported as occurring on 12/13/2021.